Apply Dual Antiplatelet Guidance After Stents for ACS

April 2025

New Am Heart Assn guidelines clarify antiplatelet options for patients with a stent after acute coronary syndromes (ACS).

Dual antiplatelet therapy (DAPT) combines aspirin with a P2Y12 inhibitor...clopidogrel (Plavix), prasugrel (Effient), ticagrelor (Brilinta).

It’s used to prevent major adverse CV events (death, nonfatal MI, stroke, etc) during and after ACS.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

  • Cutting-edge advice about new medications and how they fit into practice
  • Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
  • Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote